Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Neurology
Metadata
Title
Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis
Author
Wolfgang Brück
Publication date
01-10-2005
Publisher
Steinkopff-Verlag
Published in
Journal of Neurology / Issue Special Issue 5/2005
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-005-5003-6

Other articles of this Special Issue 5/2005

Journal of Neurology 5/2005 Go to the issue

OriginalPaper

Purely systemically active anti-inflammatory treatments are adequate to control multiple sclerosis

OriginalPaper

Multiple sclerosis trial designs for the 21st century: Building on recent lessons

OriginalPaper

Changes observed in multiple sclerosis using magnetic resonance imaging reflect a focal pathology distributed along axonal pathways

OriginalPaper

Modulating processes within the central nervous system is central to therapeutic control of multiple sclerosis

OriginalPaper

Introduction

OriginalPaper

The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage